News
Bank of America and Citigroup are banking stocks that could soar
Who likes to invest in financial stocks? Only people with a solid financial or accounting background, since they can reasonably understand the balance sheets and valuations of these stocks well
2 low-priced gene therapy stocks to speculate on
Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic differences. Gene-editing involves using
There's a new buy signal flashing for these stocks, Dalio effect?
In every market, there are markers and yardsticks - or benchmarks as they like to call them - that attract investment dollars in and out of specific vehicles and asset classes. Focusing on stocks
3 Magnificent Seven stocks are approaching potential buy zones
As the year begins and capital begins to be put to work, a new chapter is unfolding for members of the heralded 'Magnificent Seven.' As the curtains rise in 2024, these tech behemoths, the guiding
Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. Neuer 200% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. 200% Biotech Hot Stock nach 134.452% mit Biogen
08.01.24 08:03
London (www.aktiencheck.de , Anzeige)
Are defensive sectors ready to outshine growth in 2024?
Defensive sectors are off to a better start to the new year than growth stocks, which dominated in 2023.
The Health Care Select Sector SPDR Fund (NYSEARCA: XLV), which has both growth and
Are top upgrades Micron, Lululemon & CrowdStrike buys right now?
Micron Technology, Inc. (NASDAQ: MU), Lululemon Athletica Inc. (NASDAQ: LULU) and CrowdStrike Holdings Inc. (NASDAQ: CRWD) made MarketBeat’s list of most upgraded stocks in the past 90 days. Does
This biotech stock has surged over 300% this week
As the market continues to witness a resurgence in small-cap investments, led by a jump in investor optimism and speculation, there’s been a seemingly steady flow of capital back into
The 5 top-rated dividend stocks by analysts
Marketbeat.com provides many tools for investors, including analyst-tracking algorithms. A single upgrade is worthless, but a trend of upgrades can repeatedly drive a stock to new highs. Today
Can Coinbase stock still rally another 50% from here?
Coinbase Global Inc. (NASDAQ: COIN) is the largest publicly traded cryptocurrency exchange in the U.S. It is arguably the most trusted and stable exchange due to its regulatory transparency and
Will the Biotech sector sustain its momentum in 2024?
The stock market is like a bustling stage, and on the first trading day of the year, one performer stole the show while others struggled to keep up.
Is Netflix stock a buy ahead of January earnings?
Even though a 75% drop through 2022 may have disqualified Netflix Inc (NASDAQ: NFLX) from the previously untouchable FAANG group of tech stocks, the current rally of nearly 200% has certainly put
It's official, BYD has overtaken Tesla as the EV king
What a time to be an investor; there are changes coming left and right to those who call the stock market home to their savings or spare cash to be invested. The intellectual challenge is enough
Analysts expect Bank of America stock to rally 55%
A 35% rally since October meant that Bank of America (NYSE: BAC) shares finished the year on a high after what was, at best, turning into a mediocre year before that. Shares of the Wall Street
3 ways to trade options if you believe a stock will fall lower
If you believe that a stock is going to fall lower in price, then there are three kinds of options trades you can make to capitalize on the move potentially. You don't necessarily have to be a
3 mid-cap stocks that analysts love heading into earnings season
The beginning of a new year also means that a new earnings season is right around the corner. Every earnings season seems "the most important earnings season" for investors. But when every stock
Eilt: Sensationeller Durchbruch im Kampf gegen den Hautkrebs - Massives Kaufsignal. 297% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 359% mit Biotech
Eilt: Sensationeller Durchbruch im Kampf gegen den Hautkrebs. 279% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)
04.01.24 08:02
London (www.aktiencheck.de , Anzeige)
Starbucks stock is suddenly surrounded by analysts
The answer everyone is looking for in today's market is one that potentially positions portfolios in a way to benefit from the coming FED interest rate cuts in 2024. Because markets are
UniFirst stock falls into the buy zone
UniFirst (NYSE: UNF) had a decent first quarter but provided weak guidance, sending shares down nearly 10%. As bad as the move sounds, it’s a knee-jerk reaction in a stock whose future is bright
5 Reasons Under Armour stock may not trade under $10 for long
On two occasions last year, Under Armour, Inc. (NYSE:UAA) came within pennies of recovering to the $10.00 level. In 2024, the third time may not only be the charm but also unleash an extra large
4 takeaways from the first day of trading in 2024
The first day of 2024 trading has come and gone, and the signs they sent are not good. Between market leaders confirming a top, the S&P 500 (NYSEARCA: SPY) retreating, and the VIX (NDEXCBOE: VIX)
Intel stock: Analysts are expecting multi-year highs
After falling more than 50% in 2022, last year really was all about the recovery for shares of Intel Corporation (NASDAQ: INTC). They climbed throughout the year, finishing up about 100% from
Traders are suddenly stampeding these Buffett stocks
The new year is here, and some are already calling the shots about how 2024 could look. Who dominates? It will likely experience a 'trader' market in the first quarter of 2024, considering where
AT&T could be the best placeholder stock before rate cuts come
A significant shift is about to come to the financial markets, as the forces that push and pull stock prices are pivoting from one end to the opposite in the coming months. Interest rates act as a